Italy Aesthetic Injectable Market Size & Outlook, 2023-2030
Italy aesthetic injectable market, 2018-2030 (US$M)
Related Markets
Italy aesthetic injectable market highlights
- The Italy aesthetic injectable market generated a revenue of USD 361.0 million in 2023 and is expected to reach USD 746.5 million by 2030.
- The Italy market is expected to grow at a CAGR of 10.9% from 2024 to 2030.
- In terms of segment, botulinum toxin was the largest revenue generating product in 2023.
- Hyaluronic Acid is the most lucrative product segment registering the fastest growth during the forecast period.
Aesthetic injectable market data book summary
| Market revenue in 2023 | USD 361.0 million |
| Market revenue in 2030 | USD 746.5 million |
| Growth rate | 10.9% (CAGR from 2023 to 2030) |
| Largest segment | Botulinum toxin |
| Fastest growing segment | Hyaluronic Acid |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hyaluronic Acid, Botulinum Toxin, Aquatic Light Injections |
| Key market players worldwide | Ipsen SA, AbbVie Inc, Merz Pharma, Galderma Group AG Registered Shares, Prollenium Medical Technologies, Suneva Medical, Sinclair Pharma plc, Medytox, Revance Therapeutics Inc |
Other key industry trends
- In terms of revenue, Italy accounted for 3.3% of the global aesthetic injectable market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany aesthetic injectable market is projected to lead the regional market in terms of revenue in 2030.
- France is the fastest growing regional market in Europe and is projected to reach USD 991.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Aesthetic Injectable Market Scope
Aesthetic Injectable Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Italy aesthetic injectable market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to aesthetic injectable market will help companies and investors design strategic landscapes.
Botulinum toxin was the largest segment with a revenue share of 45.84% in 2023. Horizon Databook has segmented the Italy aesthetic injectable market based on hyaluronic acid, botulinum toxin, aquatic light injections covering the revenue growth of each sub-segment from 2018 to 2030.
Italy’s aesthetic injectable market is expected to be driven by the growing number of players entering into strategic partnerships and novel product launches. For instance, in June 2023, Evolus, Inc. commercialized its product made of botulinum toxin type A, Nuceiva, in Italy.
The EC approved the product to temporarily treat the appearance of vertical lines between the eyebrows. Furthermore, the company partnered with GP Dermal Solution to market its product in the country. Increasing aesthetic consciousness is boosting the demand for cosmetic procedures in the country.
According to the ISAPS report, in 2022, approximately 386,754 injectable procedures were performed in Italy, of which 212,671 involved HA fillers, 161,254 involved botulinum toxin fillers, and 12,830 involved CaHA fillers.
Reasons to subscribe to Italy aesthetic injectable market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Italy aesthetic injectable market databook
-
Our clientele includes a mix of aesthetic injectable market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy aesthetic injectable market, including forecasts for subscribers. This country databook contains high-level insights into Italy aesthetic injectable market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Italy aesthetic injectable market size, by product, 2018-2030 (US$M)
Italy Aesthetic Injectable Market Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
